ロード中...
Inducing Oncoprotein Degradation to Improve Targeted Cancer Therapy()
Over the past decade, inhibition of the kinase activities of oncogenic proteins using small molecules and antibodies has been a mainstay of our anticancer drug development effort, resulting in several Food and Drug Administration–approved cancer therapies. The clinical effectiveness of kinase-target...
保存先:
| 出版年: | Neoplasia |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Neoplasia Press
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4611070/ https://ncbi.nlm.nih.gov/pubmed/26476077 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2015.08.008 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|